Claims
- 1. A compound of the general formula:
- 2. A compound of the general formula:
- 3. A compound of the general formula:
- 4. A compound of the general formula:
- 5. A compound selected from the following group:
- 6. A compound selected from the following group:
- 7. A method for treating a mammalian disease characterized by undesirable angiogenesis, said method comprising administering to a mammal having said undesirable angiogenesis a compound of any of claims 1 through 6, said compound being administered in an amount sufficient to inhibit angiogenesis.
- 8. A method for treating a mammalian disease characterized by undesirable endothelial cell proliferation, said method comprising administering to a mammal having said undesirable endothelial cell proliferation a compound of any of claims 1 through 6, said compound being administered in an amount sufficient to inhibit endothelial cell proliferation.
PRIOR RELATED U.S. APPLICATION DATA
[0001] This application claims priority to U.S. Provisional Patent Application Serial No. 60/354,046 filed Jan. 30, 2002, the entirety of which is incorporated herein by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60354046 |
Jan 2002 |
US |